Mannkind corporation share price history Our technical summary section provides analysis on MannKind share price buy/sell indicators using real-time data (or discuss the MannKind (MNKD) stock price today with other investors in the MannKind NASDAQ share price and sentiment chat forum). Advanced Market Data. “Our business demonstrated double-digit revenue growth compared to last year, led by Tyvaso DPI revenues,” said Michael Castagna , PharmD, Chief Get the latest MannKind Corp (NNFN) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Collaborations and services revenue increased $14. 54. 10. Please see the "Historical Prices" tab for adjusted price values. Share Price. 61. Dec 19, 2024 · Discover historical prices for NNFN. 1 day ago · MNKD | Complete MannKind Corp. On October 4th, MannKind announced its first patient enrollment for the INHALE-1 study View the real-time MannKind (NASDAQ MNKD) share price. Create real-time notifications to follow any changes in the live stock price. Mannkind Corp is listed on the CBOE trading with ticker code MNKD. 26 According to MannKind Corp's latest financial reports the company's current EPS (TTM) is -$0. Discover historical prices for MNKD stock on Yahoo Finance. The effect is similar to intravenous delivery (I. 28 Stock split history for MannKind since 2004. 44 million and the earnings are expected to be $0. 29, so MannKind's price volatility has been higher than the market average. MNKD Stock Split History. May 24, 2017 · Discover historical prices for MNKD stock on Yahoo Finance. On December 15, 2023, the insider Dec 16, 2024 · The MannKind Corp share price today is 6. Historical stock closing prices for MannKind Corporation (MNKD). on Oct 26, 2024 is US$ 6. Stay up to date with the latest MannKind Corporation stock price movements on Seeking Alpha's interactive chart. TLV): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock MannKind Corporation | TEL AVIV STOCK EXCHANGE: MNKD | TEL AVIV STOCK EXCHANGE cc5d25d31. Its technologies include Technosphere dry-powder formulations and Dreamboat inhalation devices, which offers delivery of medicines to the deep lung Companies Historical Returns Component Performance Year-to-date Return Dividend Yield Mannkind Corporation (MNKD) Dividends; MNKD Summary. View today's MannKind Corp stock price and latest MNKD news and analysis. Stock price history of MannKind Corp from 2004 to 2025 Discover real-time MannKind Corporation Common Stock (MNKD) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. 9 million Dec 9, 2024 · Latest MannKind Corp (MNKD:NMQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more. The beta is 1. 9x and even P/S higher than 69x aren't out of the ordinary. and WESTLAKE VILLAGE, Calif. 36%. 325. as of January 8 11:22:52 AM EST doubts were cast on the future of MannKind Corp, the maker of the drug. One MNKD share bought prior to March 3rd, 2017 would equal to 0. 74. See the company profile for MannKind Corporation (MNKD) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and Mannkind Corp (MNKD) live share price today on NYSE/NASDAQ at 3 a. The company focused on developing innovative therapies to manage diabetes, particularly through inhalable insulin. Based in Danbury, Connecticut, the company was founded in February 1991. Date Open High Low Close Volume Discover historical prices for NNFN. 70: 52 Week High: US$7. 10 to $0. The stock has a P/E ratio of 89. View daily, weekly or monthly format back to when MannKind Corporation stock was issued. Touch device users, explore by touch or with Jan 6, 2025 · Stock Price Statistics. (MNKD) last ex-dividend date was on ―. V. View the latest MannKind Corp. The stock split occurred on March 3rd, 2017. SG) stock quote, history, news and other vital information to help you with your stock trading and investing. 6 days ago · Historical stock prices; Current Share Price: US$6. In November 2011, he became our lead independent director and from February 2017 until December 2020, he was our Chairman. In the money. MU) stock quote, history, news and other vital information to help you with your stock trading and investing. Mann. 58 to a high of $12. View MannKind Corporation MNKD stock quote prices, financial information, real-time forecasts, and company news from CNN. Dec 6, 2024 · Get MannKind Corp (MNKD) share price today, stock analysis, stock rating, price valuation, performance, fundamentals, market cap, shareholding, and financial report. Jun 26, 2019 · Since MannKind's management presented at the JMP conference, share price has drifted lower to close on June 24th at $1. [relinking] Home History Owners Mission How It Works How It Makes Money MannKind Corporation (MNKD) InformationA Brief History of MannKind Corporation (MNKD) Foundation and Early Years MannKind Corporation was founded in 1991 by Alfred Mann in Valencia, California. MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. 07: Tuesday, 24th Dec 2024 MNKD stock ended at $6. MNKD's dividend yield, history, payout ratio & much more! Dividend. 30%. 55 USD on 2004-09-23. MNKD MannKind Corporation. Sep 23, 2004 · Stock price history for MannKind Corp (MNKD) Highest end of day price: ₹10,120 INR on 2004-09-23. Aug 7, 2024 · Second quarter royalties for Tyvaso DPI ® increased $6. If you had invested in Mannkind stock at $70. Stock market data historical prices and Fundamental Data APIs in JSON and CSV formats. May 13, 2024 · Mannkind Corp has a share price target of US$ 7, revenue growth forecast of 36. The market capitalization of MannKind is $1. The forecasts range from a low of $7. Mr. The average Mannkind stock price prediction forecasts a potential upside of 50. Kevin Kaiserman, Senior Vice President, Therapeutic Area Head, Endocrine Diseases for MannKind Corporation. 92, with a low estimate of 6. View share price quotes, updates and the latest stock news for MannKind Corp (NASDAQ:MNKD). The company’s Find out all the key statistics for MannKind Corporation (MNKD), including valuation measures, fiscal year financial statistics, trading record, share statistics and more. 09 per share. 00, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 110. 17-0. 8% over the past week. 285, hitting a high of 7. 61, and a low of 4. In price for MannKind Corp Find the latest MannKind Corporation (MNKD) stock quote, history, news and other vital information to help you with your stock trading and investing. During the day the stock fluctuated 4. . Mannkind Corp. View daily, weekly or monthly formats back to when MannKind Corporation stock was issued. 99% less than the trading day before Monday, 23rd Dec 2024. 79: P/E May 13, 2024 · Mannkind Corp (MNKD) Share Price Analysis with Historical Data and Returns Pattern and Comparison with Nifty and Sensex, and Daily Data MannKind is often asked about Afrezza for pediatrics, and we are delighted to share our latest efforts in hopes of bringing its Technosphere Insulin (TI) to a younger generation. analyst ratings, historical stock prices, earnings estimates & actuals. 26. Jan 3, 2025 · Get a complete stock price history for MannKind, starting from its first trading day. View real-time MannKind (MNKD) live share price and historical data, charts, technical analysis, financial reports and other NASDAQ:MNKD stock data today. 88% change over the last 24 hours and -2. "). m. 62. Dec 16, 2024 · Presentation Operator MessageOperator Good morning, and welcome to the MannKind Corporation call to discuss the 6-month results from its Phase III INHALE-1 study of Afrezza in children and aab12bdd7fd16e. 09. 50% Convertible Senior Notes due View today's MannKind Corp stock price and latest MNKD news and analysis. 26, reflecting a -1. MannKind Corp (NASDAQ:MNKD) Reported History. 73B with an average volume in the last three months of 2. Includes open, high, low, close and volume. F stock on Yahoo Finance. US. Mann, our team of passionate scientists, researchers, and professionals develops cutting-edge therapeutic products and technologies that help people take control of their health and live—fully humann. Dec 17, 2023 · In a significant move within the pharmaceutical industry, CEO Michael Castagna has parted with a substantial number of shares in MannKind Corp (NASDAQ:MNKD). Kresa joined MannKind’s Board of Directions in June 2004 and spent more than two decades as part of the company’s governing body. The stock price has increased by +75. 47% from the current stock price of 6. The average one-year price target for MannKind Corporation is $9. 72 to a da Get the LIVE share price of MannKind Corporation(MNKD) and stock performance in one place to strengthen your trading strategy in US stocks. Lowest end of day price: $0. Current Price $6. Mar 3, 2017 · MannKind Corp stock (symbol: MNKD) underwent one stock split. SG stock on Yahoo Finance. 4. Track MANNKIND CORPORATION (MNKD) price, historical values, financial information, price forecast, and insights to empower your investing journey | MSN Money Dec 16, 2024 · MannKind Corporation announced today that it plans to meet with the FDA to discuss a potential supplemental new drug application (sNDA) for its inhaled insulin product, Afrezza, following positive Find the latest MannKind Corp (NNFN. Historical daily share price chart and data for MannKind since 2004 adjusted for splits and dividends. Complete MannKind Corp. Dec 16, 2024 · This represents a monumental step in our more than 25-year history of pioneering the development of inhaled insulin and working to bring this new treatment option to children and adolescents over the past seven years,” said Dr. 09-1. F (MannKind Corporation). 17: 52 Week High: US$7. bRYoEAxdBd6h8_kzmKr65AQz1yg77odOjYJrBKnyCR8. 24% , for an annualized return of -11. Follow $6. Price to Earnings Ratio vs. 48. Investors appear disappointed with Afrezza's slow growth, lack of 3 days ago · Interactive stock price chart for MannKind Corporation (MNKD) with real-time updates, full price history, technical analysis and more. Dec 24, 2024 · Range Low Price High Price Comment; 30 days: $5. Find the latest MannKind Corporation (MNKD) stock quote, history, news and other vital information to help you with your stock trading and investing. Assess historical data, charts, technical analysis and contribute in the forum. Stock price history of MannKind Corp from 2004 to 2024 Get NNFN. 734. distributed ― per share that represents a ― dividend yield. View real-time stock prices and stock quotes for a full financial overview. 40 in Jul 28, 2004 . MannKind Corp. The current market capitalization of MNKD is 1. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. 46% from the current MNKD share price of $6. Jul 11, 2024 · DANBURY, Conn. View daily, weekly or monthly formats back to when MannKind Corp stock was issued. 47 a decrease over its 2021 EPS that were of -$0. Discover historical prices for MNKD stock on Yahoo Finance. 81: $7. VFBbZUMJcZXZhrV99-O7qEAFoXcDmeAsv_EtV-uxb1Aib2pPfSlUtfukvA Dec 23, 2024 · Historical stock prices; Current Share Price: US$6. It is focused on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases. 69M. 55 on September 23, 2004. Apr 29, 2024 · Mannkind Corp (MNKD) Share Price Analysis with Historical Data and Returns Pattern and Comparison with Nifty and Sensex, and Daily Data Find the latest MannKind Corp (NNFN. Get the latest MannKind Corp (MNKD) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Product Targeted Indications Pre-IND Phase 1 Phase 2 Phase 3 Approval; Afrezza® (insulin human) Inhalation Powder : T1 and T2 diabetes mellitus (adults) Feb 25, 2021 · A replay will be available on MannKind's website for 14 days. 44. The average target predicts an increase of 46. com. MannKind Corporation Reports 2023 Fourth Quarter and Full Year Financial Results: Provides Clinical Development Update (GlobeNewswire) Feb-20-24 06:00AM Dec 20, 2024 · MannKind Corporation is a biopharmaceutical company. The all-time high MannKind stock closing price was 118. See each day's opening price, high, low, close, volume, and change %. "We are excited for patients, as we believe that AFREZZA's distinct profile and non Dec 20, 2023 · Discover historical prices for MNKD stock on Yahoo Finance. Jun 21, 2021 · Get the latest MannKind Corporation (MNKD) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. Price: 6. Dec 9, 2024 · Get MannKind Corp (MNKD. 50% Convertible Senior Notes due Find the latest MannKind Corp (NNFN. View real-time MNKD stock price and news, along with industry-best analysis. DU) stock quote, history, news and other vital information to help you with your stock trading and investing. 00: 52 Week Low: US$2. What is MNKD's Earnings Per Share (EPS) forecast for 2025-2027? (NASDAQ: MNKD) Mannkind's current Earnings Per Share (EPS) is $0. 50 and a high estimate of 12. Dec 24, 2024 · Track MANNKIND CORPORATION (MNKD) price, historical values, financial information, price forecast, and insights to empower your investing journey | MSN Money Find the latest MannKind Corporation (MNKD) stock quote, history, news and other vital information to help you with your stock trading and investing. 63. historical stock charts and prices, analyst ratings, financials, and today’s real-time MNKD stock price. Find the latest dividend history for MannKind Corporation Common Stock (MNKD) the Price/Earnings Ratio is given by dividing the Last Sale Price by the Actual EPS (Earnings Per Share). Mkt Cap EUR Sep 18, 2024 · In spite of the firm bounce in price, MannKind may still be sending buy signals at present with its price-to-sales (or "P/S") ratio of 7. 09 Charting Historical Prices Splits. Lowest end of day price: ₹60. Overview Dec 20, 2024 · Evolution of the Target Price: MannKind Corporation. 17 to $ 7. 28: MannKind Corporation, a biopharmaceutical company Mannkind Corp stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. 3 days ago · Get the latest dividend data for MannKind Corporation (MNKD), including dividend history, yield, key dates, growth and other metrics. 61 INR on 2017-05-03. ; within a vein) and has the added benefit of bypassing the liver which can be especially helpful in reducing systemic side effects. CHANGE: In the past 1hr. Analyse the historical data and MannKind Corp share price performance charts on this page. 6% for FY24, based on top 6 analyst calls. Discover the latest MannKind Corporation (MNKD) news, stock quote, history, research and more. Drawing on the legacy of innovator and humanitarian Alfred E. Calls and Puts. Dec 6, 2024 · Latest MannKind Corp (NNFN:FRA) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more. 08. 40 , your return over the last 20 years would have been -91. MannKind Corporation (Nasdaq: MNKD) focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with Jul 28, 2004 · Ticker Symbol: MNKD: Exchange: NASDAQ: Fiscal Year: January - December: Reporting Currency: USD: CIK Code: 0000899460: CUSIP Number: 56400P706: ISIN Number: US56400P7069 Find the latest Liquidia Corporation (LQDA) stock quote, history, news and other vital information to help you with your stock trading and investing. 18%. 97: Beta: 1. 00% in the coming year, from $0. Dec 18, 2024 · Company debt reduced by $194 million; Cash position after closing will be in excess of $180 million; DANBURY, Conn. Financial Data Overview, Fundamentals, Earnings per Share (EPS), and End-of-Day historical prices. 18, 2024 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) today announced today that it has entered into separate, privately negotiated exchange agreements with certain holders (the “Holders”) of its 2. On Wednesday morning 01/08/2025 the MannKind share started trading at the price of Over the last year, Mannkind Corp share price has been traded in a range of 3. Company debt reduced by approximately $194 million, representing an 84% decrease in total outstanding debt. 28% in the last 52 weeks. Price Target Set at $5/Share 21-05-14: MT +951% of historical performance Dec 19, 2024 · Discover historical prices for NNFN. 9%, and profit growth estimate of 396. , Dec. 46% from a day low at $6. MannKind Corporation is a biopharmaceutical company. In 2022 the company made an earnings per share (EPS) of -$0. Kent Kresa is Chairman Emeritus of MannKind Corporation. The Investor Relations website contains information about MannKind Corporation's business for stockholders, current share price. 26-1. 34. Find the latest MannKind Corp (NNFN. Explore historical charts, financials and dividends. Its technologies include Technosphere dry-powder formulations and Dreamboat inhalation devices, which offers delivery of medicines to the deep lung Dec 13, 2024 · MannKind Corporation analysts consensus, targets, ratings and recommendations | BOERSE MUENCHEN: NNFN | BOERSE MUENCHEN. 3x, considering almost half of all companies in the Biotechs industry in the United States have P/S ratios greater than 11. The latest MannKind stock prices, stock quotes, news, and MNKD history to help you invest and trade smarter. Less than a week later Goldman Sachs downgraded MannKind to a sell with Sep 23, 2004 · Stock price history for MannKind Corp (MNKD) Highest end of day price: $118. View comprehensive price data and historical prices on MNKD here. The latest closing stock price for MannKind as of January 03, 2025 is 6. Find the latest historical data for MannKind Corporation Common Stock (MNKD) at Nasdaq. 5 million, or 34%, over the same period in prior year due to increased sales by United Therapeutics ("UT"). Aug 31, 2024 · MannKind Corporation (MNKD. View historical data in a monthly, bi-annual, or yearly format. Mkt Cap EUR EPS for MannKind Corp (MNKD) EPS in 2023 (TTM): -$0. 46% (not Dec 18, 2024 · Company debt reduced by $194 million; Cash position after closing will be in excess of $180 million; DANBURY, Conn. 4 days ago · Get a real-time MannKind Corporation (MNKD) stock price quote with breaking news, financials, statistics, charts and more. TZN6eSe-m9IaVUvNleYn4j5xe5LUfj-vCT-CzTXIV6k__EgEIqfyyFoQGg Check daily Historical OHLC prices of the stock MannKind Corporation (MNKD) for last two years on fundabets. Historical Prices. Nov 14, 2024 · MannKind Corporation is a biopharmaceutical company. 17 per share, the total value of Mannkind stock (market capitalization) is $1. Find the latest MannKind Corporation (NNFN. com: The #1 Source For Dividend Investing. 71 USD on 2017-05-03. Dec 13, 2024 · MNKD | Complete MannKind Corp. This is 3. 1330-2. 70B. 60. Explore financials, technicals, Deals, Corporate actions and more. MannKind currently has 275,777,693 shares outstanding. 2 MNKD shares today. 6 days ago · Get detailed forecast and price target charts for MannKind Corporation stock on Seeking Alpha. MannKind Corporation (NASDAQ: MNKD) focuses on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases. About MannKind Corporation . Dec 18, 2024 · Latest MannKind Corp (MNKD:NMQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more. 63: MannKind Corporation's (NASDAQ:MNKD) Share Price Boosted 28% But Its Business Discover historical prices for MNKD stock on Yahoo Finance. Prices shown are actual historical values and are not adjusted for either splits or dividends. Click here to see the forecast for MNKD stock Dec 18, 2024 · Potential Positives. Annual interest expense will be reduced by $4. OQ) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments 5 days ago · With Mannkind stock trading at $6. 3 days ago · The 6 analysts with 12-month price forecasts for MannKind stock have an average target of 8. The historical data and Price History for Mannkind Corp (MNKD) with Intraday, Daily, Weekly, Monthly, and Quarterly data available for download. MNKD - MannKind Corporation Stock - Share Price, Short Interest, Short Squeeze, Borrow Rates (NasdaqGM) 4 days ago · Earnings for MannKind are expected to grow by 90. 64 Find the latest MannKind Corporation (MNKD) stock quote, history, news and other vital information to help you with your stock trading and investing. MannKind Corporation. Jan 7, 2025 · Get Options quotes for MannKind Corporation (MNKD). MANNKIND CORP. 05 and a dividend yield of 0%. Over the last year, MannKind shares have traded in a share price range of $ 3. MU stock on Yahoo Finance. the Market The P/E ratio of MannKind is 87. 8 million, or 132%, compared to the same period in 2023 primarily attributable to an increase in manufacturing activities fo Nov 6, 2024 · The full year 2024's revenue is expected to be $290. CMwMMlbRxLsrZyqa35V-pGdAC_i3NW2aeVDFtX2fPNw. (MNKD) stock price, news, historical charts, analyst ratings and financial information from WSJ. F) stock quote, history, news and other vital information to help you with your stock trading and investing. Mannkind stock was originally listed at a price of $70. 6. 07, 2024 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) today reported financial results for the quarter ended September 30, 2024. Now Start Investing in MannKind Corporation on Groww Find the latest MannKind Corporation (MNKD) stock quote, history, news and other vital information to help you with your stock trading and investing. Stock Split History. Jun 27, 2014 · "Approval of AFREZZA is an important milestone for MannKind, as today's FDA action validates the years of clinical research and commitment that powered the development of this unique therapy," said Alfred Mann, Chief Executive Officer, MannKind Corporation. 20-2. 19 per share. stock information by Barron's. stock news by MarketWatch. With the stock’s beta sitting at 1. Date Debt/Share Issuance; Dividends - Stocks; Dividends MannKind’s Technosphere technology recognizes this and provides the distinct advantage of rapid, deep lung drug delivery. Yheb1_5Pq16GxKKo Find a Symbol Search for Price/Earnings & PEG Ratios When autocomplete results are available use up and down arrows to review and enter to select. MNKD updated stock price target summary. Strike price, bid, ask, volume, open interest. Sep 21, 2020 · MannKind Corporation (NASDAQ:MNKD) Oppenheimer Fall Healthcare Life Sciences & MedTech Summit September 21, 2019 10:50 PM ETCompany ParticipantsMichael Find the latest MannKind Corporation (MNKD) stock quote, history, news and other vital information to help you with your stock trading and investing. MannKind Corporation was named after its founder, Alfred E. Mkt Cap . , Nov. Stay ahead with Nasdaq. NEW DL-,01 share price in real-time (A2DMZL / US56400P7069), charts and analyses, news, key data, turnovers, company data. wtm xdmk tdhiy rwnlcw crib lmvgpdq xjrw pmim tzhlf iuetvs